
Overview
I focus on treating patients with blood cancers who are considering stem cell or bone marrow transplantation. There have been significant improvements in transplantation over the last 20 years, which has improved outcomes. These improvements include the ability to use lower doses of chemotherapy to reduce toxicity for patients, as well as strategies to reduce the risk of relapse. I am interested in using new therapies and approaches to improve outcomes after stem cell transplantation for blood cancers. It is important to work together with patients to determine their goals for treatment and select the best path forward. I have enjoyed working with patients and their families for many years after their transplant.
Dr. Alyea-Iii is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Transplant.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
2400 Pratt St, Durham, NC 27705
Duke Blood Cancer Center
I care for patients who are diagnosed with lymphoma. I am really passionate about my work because our scientific understanding of lymphoma is rapidly increasing. This new knowledge is helping us care for our patients better. I strive to understand my patients, both how they feel physically and emotionally. I aim to guide my patients through the best treatment options for them. These choices may include new treatments and clinical trials. I always try to treat my patients like my own family. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.
University Of North Carolina At Chapel Hill
Christopher Dittus is a Hematologist Oncology specialist and an Emergency Medicine provider in Chapel Hill, North Carolina. Dr. Dittus is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dittus is currently accepting new patients.
Duke Blood Cancer Center
I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Alyea-Iii isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Alyea-Iii isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndrome (MDS)Dr. Alyea-Iii isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid LeukemiaDr. Alyea-Iii isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Alyea-Iii isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Alyea-Iii isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Alyea-Iii isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Graft Versus Host Disease (GvHD)Dr. Alyea-Iii isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Alyea-Iii isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Anaplastic Large Cell LymphomaDr. Alyea-Iii isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaDr. Alyea-Iii isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantDr. Alyea-Iii isExperienced. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)Dr. Alyea-Iii isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Chronic Myelomonocytic Leukemia (CMML)Dr. Alyea-Iii isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).


